Clinical Trial Update: Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) [Phase 3]

View source ↗

Summary

A multi-center single-arm Phase 3 trial evaluating the effectiveness of varying warfarin therapy duration in patients with heparin-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Marshall University | Conditions: Heparin-induced Thrombocytopenia | Phase 3 | Status: UNKNOWN